Insider Sale: ESAB Proposed Sale of 4,067 Shares via Fidelity on NYSE

Rhea-AI Filing Summary

ESAB Corporation submitted a Rule 144 notice disclosing a proposed sale of 4,067 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $459,760.50. The filing lists 60,698,710 shares outstanding. The securities are shown as originating from an option granted on 05/13/2019, recorded as acquired and paid in cash on 08/13/2025. The document also reports a prior sale of 1,500 shares on 06/11/2025 for $189,633.60. The filer certifies they are unaware of any undisclosed material adverse information.

Positive

• Rule 144 disclosure filed, demonstrating compliance with securities transfer rules
• Sale routed through Fidelity on the NYSE, which supports transparent execution

Negative

• Insider liquidity event documented: planned sale of 4,067 shares
• Additional recent sale recorded: 1,500 shares sold on 06/11/2025 for $189,633.60

Insights

Securities Analyst

TL;DR: Insider plans to sell 4,067 shares (~$460k); prior 1,500-share sale also reported; routine Rule 144 disclosure.

The filing documents a proposed sale of 4,067 common shares via Fidelity on the NYSE with an aggregate market value of $459,760.50. It notes the shares derive from an option granted on 05/13/2019 and were recorded as acquired and paid in cash on 08/13/2025. A prior sale of 1,500 shares on 06/11/2025 for $189,633.60 is disclosed. This is a compliance-focused disclosure under Rule 144 rather than a change to operating results; no earnings or material corporate events are referenced.

Corporate Governance Expert

TL;DR: Form 144 filed and signed representation made that no undisclosed material adverse information exists; transaction stems from option exercise.

The notice includes the standard seller representation that no undisclosed material adverse information is known. The securities to be sold are linked to an option granted in 2019, with acquisition and cash payment recorded on 08/13/2025. The filing identifies execution through a registered broker, providing transparent market routing. The disclosure is procedurally complete in the material provided, but the identity of the primary filer field is not populated in the issuer/person table of the document.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4067	459760.50	60698710	08/13/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/13/2025	Option Granted - 05/13/2019	Issuer			4067	08/13/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Rhonda L. Jordan 909 Rose Avenue 8th Floor North Bethesda MD 20852	Common	06/11/2025	1500	189633.60

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by ESAB (ESAB) disclose?

The filing discloses a proposed sale of 4,067 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $459,760.50.

Who is identified as selling shares in the filing?

The table reporting sales during the past three months names Rhonda L. Jordan as the seller of 1,500 shares on 06/11/2025; the primary filer/person field for the proposed sale is not explicitly populated in the issuer/person table provided.

When and how were the shares being sold acquired?

The securities to be sold are listed as acquired on 08/13/2025 with the nature of acquisition shown as Option Granted - 05/13/2019, and payment noted as cash on 08/13/2025.

How many ESAB shares outstanding does the filing show?

The filing lists 60,698,710 shares outstanding.

What prior sale of the issuer's shares is reported in the filing?

The document reports a sale of 1,500 shares on 06/11/2025 with gross proceeds of $189,633.60.